🇺🇸 antilymphocyte serum in United States

102 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cytomegalovirus Infection — 19 reports (18.63%)
  2. Lung Infection — 12 reports (11.76%)
  3. Pyrexia — 12 reports (11.76%)
  4. Off Label Use — 10 reports (9.8%)
  5. Leukopenia — 9 reports (8.82%)
  6. Pathogen Resistance — 9 reports (8.82%)
  7. Pneumonia Cytomegaloviral — 9 reports (8.82%)
  8. Renal Failure — 8 reports (7.84%)
  9. Diarrhoea Infectious — 7 reports (6.86%)
  10. Escherichia Infection — 7 reports (6.86%)

Source database →

Other Immunology approved in United States

Frequently asked questions

Is antilymphocyte serum approved in United States?

antilymphocyte serum does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for antilymphocyte serum in United States?

National Heart, Lung, and Blood Institute (NHLBI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.